Deeponcology.ai
Deeponcology.ai24About
What does Deeponcology.ai do?
Deeponcology.ai aims to bridge the gap between imaging science and clinical cancer research. They focus on integrating oncology, artificial intelligence, and computer vision to develop clinically significant imaging applications, leveraging deep learning for advanced prospects in cancer diagnosis and treatment.
What is Deeponcology.ai's revenue?
StartupHub estimates Deeponcology.ai's annual revenue at $353K (range $226K to $845K, 68% confidence), based on comparable companies in the sector.
When was Deeponcology.ai founded?
Deeponcology.ai was founded in 2018.
What industry does Deeponcology.ai operate in?
Deeponcology.ai operates in Healthcare, Medical Imaging, Cancer, HealthTech, MedTech, AI-Driven Drug Discovery.
How many employees does Deeponcology.ai have?
Deeponcology.ai has approximately 2 people on record.
What is Deeponcology.ai's current status?
Deeponcology.ai's current operating status is: Inactive.
Ultimed develops an AI-powered platform to streamline medical imaging analysis and reporting for radiologists.
Antaros Medical provides innovative imaging solutions and insights for clinical drug development in metabolic, fibrotic, and inflammatory diseases.
Developing innovative AI-powered surgical navigation and planning solutions for enhanced surgical outcomes.
An entrant is a company tagged Medical Imaging whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.